background
despit
grow
evid
suggest
potenti
associ
innat
adapt
immun
viralinduc
acut
asthma
pauciti
data
area
object
studi
aim
investig
associ
innat
adapt
immun
acut
asthma
attack
analys
role
protein
cathelicidin
vitamin
cytokin
materi
method
prospect
studi
includ
patient
viralinduc
acut
asthma
children
control
asthma
nasopharyng
swab
sampl
collect
viru
identif
asthma
attack
score
assess
acut
asthma
group
blood
sampl
cathelicidin
vitamin
level
spirometr
indic
employ
result
serum
cathelicidin
level
acut
asthma
group
significantli
higher
vitamin
level
lower
control
asthma
group
p
cathelicidin
p
vitamin
p
serum
level
show
signific
neg
correl
age
p
p
spirometr
indic
p
asthmat
signific
posit
correl
paramet
asthma
attack
sever
p
acut
asthma
group
higher
cathelicidin
valu
show
signific
posit
relat
beta
coeffici
p
serum
level
higher
pgml
sensit
relat
cathelicidin
acut
asthma
attack
specif
p
predict
virusinduc
asthma
serum
vitamin
level
found
significantli
relat
viralasthma
attack
aor
p
vitamin
aor
p
conclus
innat
immun
biomark
serum
cathelicidin
use
predict
viralinduc
acut
asthma
biomark
may
provid
potenti
new
treatment
target
acut
asthma
asthma
exacerb
major
burden
healthcar
system
contribut
significantli
morbid
mortal
viral
respiratori
tract
infect
play
import
role
asthma
exacerb
pathogenesi
viralinduc
asthma
poorli
understood
clearli
differ
pathogenesi
allergeninduc
asthma
understand
mechan
viralinduc
exacerb
would
use
clinic
manag
acut
asthma
attack
innat
immun
system
play
crucial
role
defens
microb
well
initi
inflammatori
respons
cathelicidin
multifunct
host
defens
molecul
sever
effect
innat
adapt
immun
system
may
relev
modul
infect
fig
potenti
influenc
modul
tolllik
receptor
tlr
mediat
respons
activ
variou
cell
popul
involv
inflammatori
process
cathelicidin
also
promot
product
type
interferon
import
part
innat
immun
respons
microb
role
cathelicidin
viralinduc
asthma
exacerb
well
known
inflammatori
process
asthma
includ
multipl
cell
type
mediat
quit
complex
activ
tlr
shown
play
import
role
pathogen
recognit
lead
signal
transduct
involv
rang
cytokin
chemokin
ifngammainduc
protein
chemokin
involv
innat
adapt
immun
secret
cell
stimul
type
ii
ifn
lipopolysaccharid
express
observ
mani
inflammatori
diseas
consid
play
import
role
recruit
activ
cell
site
tissu
inflamm
also
shown
increas
airway
asthmat
howev
regul
inflamm
viralinduc
asthma
still
remain
elus
date
studi
yet
evalu
associ
cathelicidin
viralinduc
acut
asthma
vitamin
vit
sever
effect
innat
adapt
immun
system
may
relev
modul
sever
asthma
attack
previou
studi
show
vit
inhibit
secret
concentrationdepend
manner
increas
transcript
innat
immun
protein
human
cathelicidin
antimicrobi
peptid
despit
accumul
evid
suggest
potenti
associ
innat
adapt
immun
viralinduc
acut
asthma
data
area
scarc
aim
studi
investig
underli
mechan
viralinduc
asthma
exacerb
determin
associ
innat
adapt
immun
acut
asthma
analys
role
cathelicidin
tlr
cytokin
asthmat
patient
admit
pediatr
allergi
outpati
clinic
asthma
exacerb
routin
control
visit
novemb
februari
includ
studi
classif
asthma
sever
control
assess
accord
criteria
global
initi
asthma
control
asthma
defin
absenc
nocturn
daytim
symptom
limit
activ
need
rescu
treatment
normal
lung
function
test
last
month
asthma
attack
defin
presenc
progress
cough
wheez
dyspnea
chest
tight
accompani
low
forc
expiratori
volum
valu
previous
diagnos
asthmat
patient
asthma
attack
score
pulmonari
index
score
need
system
steroid
hospit
number
bronchodil
first
h
attack
also
assess
patient
acut
asthma
group
regular
medic
record
patient
asthma
attack
control
asthma
group
match
mild
moder
sever
previou
three
month
monosensitis
hous
dust
mite
inclus
criteria
follow
presenc
symptom
upper
respiratori
tract
infect
urti
acut
asthma
group
symptom
urti
preced
six
week
control
asthma
group
exclus
criteria
follow
presenc
chronic
lung
diseas
sever
asthma
sensit
allergen
mite
use
drug
chronic
diseas
affect
level
serum
vit
children
ask
presenc
symptom
urti
criteria
clinic
manifest
urti
defin
two
follow
symptom
fever
cough
headach
sneezingrunni
nosenas
congest
pharyng
hyperemia
sore
throat
lung
function
conduct
blood
sampl
accord
atser
guidelin
maximum
midexpiratori
flow
mmef
bronchodil
revers
record
data
analysi
allergen
sensit
evalu
skin
test
perform
accord
isaac
protocol
follow
antigen
appli
volar
surfac
forearm
addit
histamin
salin
control
dermatophagoid
pteronyssinu
dermatophagoid
farina
cockroach
cat
dog
dander
alternaria
alternata
mix
grass
tree
pollen
test
consid
posit
maxim
diamet
wheal
mm
subtract
maxim
diamet
neg
control
bodi
mass
index
bmi
calcul
weight
kilogram
divid
height
squar
meter
record
level
serum
raybiotech
inc
norcross
usa
human
cathelicidin
antimicrobi
peptid
camp
uscn
life
scienc
inc
houston
texa
usa
cusabio
biotech
co
ltd
wuhan
china
measur
elisa
use
enzymelink
immunosorb
assay
serum
level
analyz
highperform
liquid
chromatographi
system
tandem
mass
spectrometri
chromsystem
grafelf
germani
moreov
total
ige
level
eosinophil
count
measur
perform
marker
allergi
cytokin
raybiotech
inc
norcross
usa
diasourc
immunoassay
sa
nivel
belgium
measur
serum
patient
elisa
assay
peripher
blood
mononuclear
cell
isol
ficol
centrifug
lymphocyt
gate
basi
forward
side
scatter
properti
use
facscalibur
flow
cytometri
becton
dickinson
new
jersey
usa
peripher
blood
posit
cell
number
studi
reg
cell
determin
absolut
count
cell
asthma
attack
group
blood
sampl
taken
time
point
patient
admit
hospit
asthma
exacerb
nasopharyng
swab
sampl
collect
children
acut
asthma
use
multiplexpcr
seegen
inc
seoul
korea
nasopharyng
swab
sampl
test
differ
virus
rhinoviru
abc
respiratori
syncyti
viru
enterovirus
coronavirus
metapneumoviru
human
bocaviru
influenza
b
virus
adenoviru
parainfluenza
viru
studi
approv
clinic
research
ethic
committe
mersin
univers
patient
provid
written
inform
consent
prior
take
part
studi
statist
analys
perform
use
spss
statist
softwar
window
shapiro
wilk
test
perform
test
suitabl
normal
distribut
numer
data
descript
analys
present
use
median
minimum
maximum
variabl
distribut
normal
mean
standard
deviat
sd
normal
distribut
variabl
unadjust
comparison
made
use
independ
sampl
ttest
mann
whitney
u
test
continu
endpoint
chisquar
test
categor
endpoint
logarithm
cathelicidin
calcul
wide
rang
valu
correl
assess
use
spearman
correl
test
possibl
factor
identifi
univari
analysi
p
one
consid
data
present
median
standard
deviat
normal
distribut
variabl
categor
variabl
present
frequenc
percentag
data
present
median
minimum
maximum
valu
nonnorm
distribut
variabl
clinic
import
enter
multipl
regress
analysi
determin
independ
predictor
multipl
linear
regress
model
use
identifi
independ
predictor
serum
level
risk
factor
could
influenc
develop
asthma
attack
evalu
asthmat
multipl
logist
analysi
roc
curv
analysi
perform
determin
cutoff
valu
predict
develop
viral
asthma
attack
odd
ratio
confid
interv
estim
p
valu
less
consid
statist
signific
total
children
patient
viralinduc
asthma
attack
patient
control
asthma
enrol
mean
age
year
patient
femal
mean
age
asthma
attack
group
significantli
lower
control
asthma
group
p
differ
found
two
asthma
group
term
gender
inhal
corticosteroid
usag
bmi
marker
allergi
total
ige
serum
eosinophil
among
sampl
patient
acut
asthma
parainfluenza
viru
detect
rhinoviru
six
rsv
six
adenoviru
five
influenza
viru
four
coronaviru
two
median
serum
level
pgml
acut
asthma
group
pgml
control
asthma
group
differ
group
signific
p
mean
log
camp
level
also
significantli
higher
acut
asthma
group
control
asthma
group
p
median
serum
vit
level
gl
acut
asthma
group
gl
control
asthma
group
differ
two
group
highli
signific
p
differ
found
group
term
level
serum
level
lower
acut
asthma
group
control
asthma
p
signific
differ
term
cytokin
number
reg
cell
tabl
serum
level
show
signific
neg
correl
age
spearman
correl
coeffici
rho
p
level
spearman
correl
coeffici
rho
p
posit
correl
serum
cathelicidin
level
spearman
correl
coeffici
rho
p
fig
neg
correl
found
vit
border
signific
p
signific
correl
found
level
gender
bmi
ic
usag
total
ige
absolut
eosinophil
count
reg
cell
cytokin
among
asthma
patient
univari
analysi
tabl
signific
neg
correl
found
serum
level
spirometr
indic
rho
tabl
correl
found
need
system
steroid
hospit
serum
cathelicidin
level
show
signific
posit
correl
spearman
correl
coeffici
rho
p
neg
correl
spearman
correl
coeffici
rho
p
spearman
correl
coeffici
rho
p
spearman
correl
coeffici
rho
p
level
signific
correl
found
cathelicidin
reg
cell
cytokin
multipl
linear
regress
analysi
possibl
factor
could
influenc
serum
level
acut
asthma
group
reveal
higher
cathelicidin
valu
show
signific
posit
relat
beta
coeffici
p
tabl
roc
analysi
serum
level
higher
pgml
found
significantli
relat
risk
viralinduc
asthma
attack
auc
p
sensit
specif
fig
order
evalu
relat
level
viralinduc
asthma
attack
risk
factor
could
relat
acut
asthma
includ
multipl
analysi
asthmat
serum
pgml
vit
level
found
significantli
relat
risk
viral
asthma
attack
logist
regress
analysi
aor
p
vit
aor
p
independ
age
sex
use
inhal
steroid
bmi
serum
level
cathelicidin
tabl
inflammatori
process
asthma
includ
multipl
cell
type
mediat
quit
complex
nevertheless
pathogenesi
viralinduc
asthma
clearli
differ
pathogenesi
allergeninduc
asthma
poorli
understood
present
studi
show
serum
cathelicidin
level
significantli
higher
vit
level
lower
acut
asthma
group
control
asthma
serum
level
show
signific
neg
correl
age
invers
correl
found
cathelicidin
level
higher
cathelicidin
valu
found
posit
relat
serum
level
acut
asthma
group
signific
posit
correl
found
paramet
asthma
attack
sever
moreov
signific
neg
correl
found
serum
level
spirometr
indic
demonstr
high
serum
level
predict
viralinduc
acut
asthma
viral
respiratori
tract
infect
long
recogn
among
import
trigger
asthma
attack
research
mechan
viralinduc
asthma
attack
focus
rhinoviru
identif
impair
innat
immun
asthma
suggest
possibl
mechan
virusinduc
asthma
exacerb
virus
recogn
tlr
import
compon
innat
immun
interact
viru
tlr
signal
cascad
result
activ
type
interferon
proinflammatori
cytokin
also
confirm
serum
level
significantli
higher
viralinduc
asthma
attack
group
anoth
innat
immun
molecul
human
cathelicidin
antimicrobi
peptid
multifunct
host
defenc
molecul
essenti
normal
immun
respons
infect
addit
antimicrobi
effect
cathelicidin
also
immunomodulatori
properti
chemoattract
function
inhibit
neutrophil
apoptosi
tissu
regener
cytokin
releas
previou
studi
suggest
cathelicidin
could
use
marker
strong
system
immun
respons
viral
bacteri
infect
similarli
current
studi
previou
report
reveal
serum
cathelicidin
level
significantli
higher
viralinduc
acut
asthma
group
although
exact
reason
depend
product
age
remain
elus
reason
could
relat
immun
respons
viru
infect
studi
kato
et
al
serum
show
invers
correl
age
similarli
demonstr
signific
neg
correl
serum
age
work
need
explor
relationship
age
product
type
ifn
import
part
innat
immun
respons
microb
antimicrobi
peptid
cathelicidin
promot
type
ifn
product
recent
cathelicidin
observ
augment
express
antivir
activ
induc
doublestrand
rna
keratinocyt
present
studi
higher
cathelicidin
valu
found
signific
factor
could
influenc
serum
level
could
measur
type
ifn
higher
valu
acut
asthma
group
could
depend
overproduct
type
ifn
possibl
upregul
cathelicidin
found
signific
differ
product
two
asthma
group
despit
higher
serum
level
acut
asthma
group
recent
report
shown
induc
bronchial
epitheli
cell
infect
rhinoviru
mechan
depend
prior
induct
either
type
ifn
serum
cathelicidin
level
show
signific
posit
correl
neg
correl
level
studi
previou
studi
show
human
cathelicidin
elicit
modest
upregul
gen
express
peripher
blood
mononuclear
cell
antiinflammatori
properti
cathelicidin
demonstr
antagonist
action
respons
addit
may
also
contribut
antagonist
action
overexpress
decreas
releas
eosinophil
recruit
airway
ovasensit
mous
model
interact
receptor
highli
express
activ
nkt
cell
stimul
migrat
cell
cell
express
associ
inflamm
even
report
show
antagonist
effect
cell
mediat
immun
respons
modul
tlr
function
cathelicidin
consid
antiinflammatori
effect
cathelicidin
downregul
signal
wherea
stabil
ligand
enhanc
viral
respons
transmit
via
receptor
bronchial
epitheli
cell
although
cathelicidin
molecul
gener
antiinflammatori
effect
tlr
stimul
inhibit
proinflammatori
cytokin
releas
monocyt
cell
stimul
enhanc
abrog
inflammatori
signal
depend
cell
type
microenviron
present
studi
signific
neg
correl
cathelicidin
shown
relationship
less
well
character
synergist
antagonist
effect
pathway
may
stimulu
depend
wood
et
al
show
gen
express
sputum
correl
viralinduc
acut
asthma
vit
sever
effect
innat
adapt
immun
system
vit
shown
inhibit
gene
protein
express
vitamin
receptorretinoid
x
receptor
complex
vitamin
receptor
agonist
reduc
releas
power
chemokin
drive
inflamm
kuo
et
al
found
oh
vitamin
could
significantli
suppress
chemokin
moreov
banerje
et
al
found
calcitriol
inhibit
secret
concentrationdepend
manner
cell
although
found
neg
correl
vitamin
border
signific
lower
serum
vitamin
level
viralinduc
acut
asthma
could
consid
contribut
higher
level
exist
mast
cell
airway
characterist
featur
asthma
mast
cell
express
receptor
known
ligand
viral
infect
may
lead
releas
bronchial
epithelium
enhanc
asthmat
airway
inflamm
migrat
activ
mast
cell
airway
smooth
muscl
data
clearli
indic
individu
preexist
asthmat
airway
inflamm
capabl
worsen
inflamm
bronchoconstrict
moreov
involv
may
explain
lack
corticosteroid
efficaci
virusinduc
asthma
wark
et
al
confirm
level
serum
subject
acut
asthma
strongli
associ
sever
airflow
obstruct
reduc
bronchodil
respons
previou
studi
medoff
et
al
show
contribut
airway
hyperreact
airway
inflamm
mous
model
asthma
present
studi
signific
posit
correl
found
paramet
asthma
attack
sever
acut
asthma
group
also
signific
neg
correl
found
serum
level
spirometr
indic
final
present
studi
demonstr
serum
level
predict
viralinduc
acut
asthma
serum
valu
pgml
found
significantli
relat
increas
viralinduc
asthma
attack
similarli
wark
et
al
found
increas
serum
level
combin
low
level
highli
predict
viralinduc
acut
asthma
demonstr
increas
level
pgml
higher
strong
predictor
viru
trigger
asthma
exacerb
kato
et
al
also
reveal
serum
novel
marker
viralinduc
acut
asthma
limit
studi
rel
small
sampl
size
lack
sputum
tlr
cathelicidin
level
therefor
correl
local
immun
respons
lung
cathelicidin
level
could
inform
could
evalu
strength
studi
first
clinic
studi
evalu
role
tlr
cathelicidin
simultan
viralinduc
asthma
exacerb
children
studi
demonstr
associ
cathelicidin
viralinduc
acut
asthma
report
literatur
regard
studi
shed
light
pathogenesi
viralinduc
acut
asthma
also
futur
studi
evalu
cathelicidin
marker
viral
asthma
attack
moreov
studi
add
understand
role
innat
adapt
immun
viralinduc
acut
asthma
conclus
studi
demonstr
cathelicidin
show
signific
relat
develop
viral
asthma
exacerb
biomark
use
clinic
manag
asthma
exacerb
also
provid
potenti
new
treatment
target
acut
asthma
author
declar
experi
perform
human
anim
investig
confidenti
data
author
declar
follow
protocol
work
center
public
patient
data
patient
includ
studi
receiv
suffici
inform
given
inform
consent
write
particip
studi
right
privaci
inform
consent
author
obtain
inform
consent
patient
andor
subject
mention
articl
author
correspond
possess
document
